NCT01375699View on ClinicalTrials.gov

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 11, 2011

Primary Completion Date

August 4, 2017

Study Completion Date

January 19, 2018

Conditions
Breast CancerGastrointestinal CancerGenitourinary CancerSarcomaGynecologic Cancer
Interventions
DRUG

Doxorubicin

As prescribed by treating provider.

DRUG

Sildenafil

Given PO, by mouth

Trial Locations (1)

23298-0037

Virginia Commonwealth University/Massey Cancer Center, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT01375699 - Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers | Biotech Hunter | Biotech Hunter